Metformin Reduces the Incidence of Sensorineural Hearing Loss in Patients With Type 2 Diabetes Mellitus: A Retrospective Chart Review

Introduction and objectives Acquired sensorineural hearing loss (SNHL) has become a critical societal issue in recent years. SNHL is considered a risk factor for type 2 diabetes mellitus (T2DM). Metformin is commonly used to treat T2DM. However, its effects on SNHL have not been reported yet. Hence,...

Descripción completa

Detalles Bibliográficos
Autores principales: Miwa, Toru, Kita, Tomoko, Yamaguchi, Taro, Sakamoto, Tatsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Otolaryngology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669516/
https://www.ncbi.nlm.nih.gov/pubmed/36407271
http://dx.doi.org/10.7759/cureus.30406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669516/
https://www.ncbi.nlm.nih.gov/pubmed/36407271
http://dx.doi.org/10.7759/cureus.30406

Ejemplares similares